Singapore: The Chinese Ministry of Human Resources and Social Security recently announced the updation of key list of medicines covered by basic medical insurance schemes. Inclusion on the National Reimbursement Drug List...
Minoryx Therapeutics, a drug development company specialized in the discovery and development of new drugs for orphan diseases, announces that its lead compound MIN-102 has been granted Orphan Drug Designation by the US Food...
Apollo Therapeutics, the collaborative venture between three world-leading UK universities and three global pharmaceutical companies, has invested in and launched the first of its drug discovery programmes in collaboration...
Agilent Technologies Inc. has received two awards in recognition of its contributions to a long-term strategic technical partnership with The Dow Chemical Company. The awards were presented to Agilent Technologies at WesTEC,...
Singapore: Taipei based Zhenjuntang Biotechnology aims to cure cancer through a mushroom -stout camphor fungus, also called "niu... Read more
A Mauritius based R&D Laboratory recently announced the launch of its development and manufacturing activities in BioPark, Mauritius.... Read more
Student athletes from the University of Wyoming (UW) are being asked to volunteer in a clinical study to further development of... Read more
Takeda Pharmaceutical Company Limited announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash. "We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals. The addition... Read more
Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris' proprietary and patented oral peptide and small molecule... Read more
Boehringer Ingelheim announced a collaboration with Weill Cornell Medicine to identify new treatment approaches for chronic obstructive pulmonary disease (COPD) in order to develop novel treatments that could possibly halt or even reverse... Read more
Singapore: WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired HD Biosciences (HDB), a biology focused preclinical drug discovery and contract research... Read more